Lantheus Holdings logo

LNTH

Lantheus Holdings

$61.27

Earnings Summary

Revenue
$239.29Mn
Net Profits
$61.23Mn
Net Profit Margins
25.59%

Highlights

Revenue:

Lantheus Holdings’s revenue jumped 134.43% since last year same period to $239.29Mn in the Q3 2022. On a quarterly growth basis, Lantheus Holdings has generated 6.96% jump in its revenue since last 3-months.

Net Profits:

Lantheus Holdings’s net profit jumped 556.44% since last year same period to $61.23Mn in the Q3 2022. On a quarterly growth basis, Lantheus Holdings has generated 42.21% jump in its net profits since last 3-months.

Net Profit Margins:

Lantheus Holdings’s net profit margin jumped 294.7% since last year same period to 25.59% in the Q3 2022. On a quarterly growth basis, Lantheus Holdings has generated 32.96% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Lantheus Holdings post its latest quarter earnings

EPS Estimate Current Quarter
0.85
EPS Estimate Current Year
0.85

Highlights

EPS Estimate Current Quarter:

Lantheus Holdings’s earning per share (EPS) estimates for the current quarter stand at 0.85 - a 2.69% jump from last quarter’s estimates.

EPS Estimate Current Year:

Lantheus Holdings’s earning per share (EPS) estimates for the current year stand at 0.85.

Key Ratios

Key ratios of the Lantheus Holdings post its Q2 2022 earnings

Earning Per Share (EPS)
0.89
Return on Assets (ROA)
0.16
Return on Equity (ROE)
0.19

Highlights

Earning Per Share (EPS):

Lantheus Holdings’s earning per share (EPS) jumped 709.09% since last year same period to 0.89 in the Q2 2022. This indicates that the Lantheus Holdings has generated 709.09% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Lantheus Holdings’s return on assets (ROA) stands at 0.16.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Lantheus Holdings’s return on equity (ROE) stands at 0.19.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-04-29
0.46
0.97
110.87%
2022-08-04
0.7
0.89
26.62%

Company Information

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow™ serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden.

Organisation
Lantheus Holdings
Headquarters
331 Treble Cove Road, North Billerica, MA, United States, 01862
Employees
612
Industry
Health Technology
CEO
Mary Heino

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*